InvestSMART

MGC Pharmaceuticals Ltd (ASX: MXC) - Announcements

Current share price for MXC : $0.420 0.01 (2.44%)+

ASX company news and announcements for MGC Pharmaceuticals Ltd (MXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MGC Pharmaceuticals Ltd (MXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MGC Pharmaceuticals Ltd (MXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MGC Pharmaceuticals Ltd (MXC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Application for quotation of securities - MXC 7 Apr 2022 4:11PM $0.023 $0.420 risen by 1,726.09%
$18 Notification of cessation of securities - MXC 7 Apr 2022 2:59PM $0.024 $0.420 risen by 1,687.23%
$18 Notification of cessation of securities - MXC 6 Apr 2022 6:33PM $0.025 $0.420 risen by 1,580%
$18 Sciensus Rare EU & UK Sales and Distribution Agreement 5 Apr 2022 4:09PM $0.023 $0.420 risen by 1,726.09%
$18 Retirement of Joint Company Secretary 10 Mar 2022 3:34PM $0.024 $0.420 risen by 1,687.23%
$18 Half Yearly Report and Accounts 1 Mar 2022 8:09AM $0.026 $0.420 risen by 1,515.38%
$18 s708A(5)(e) Cleansing Notice 22 Feb 2022 4:53PM $0.025 $0.420 risen by 1,580%
$18 Application for quotation of securities - MXC 22 Feb 2022 4:46PM $0.025 $0.420 risen by 1,580%
$18 Results of Meeting 17 Feb 2022 8:08AM $0.028 $0.420 risen by 1,400%
$18 s708A(5)(e) Cleansing Notice 2 Feb 2022 8:21AM $0.031 $0.420 risen by 1,254.84%
$18 Application for quotation of securities - MXC 2 Feb 2022 8:21AM $0.031 $0.420 risen by 1,254.84%
$18 Application for quotation of securities - MXC 2 Feb 2022 8:21AM $0.031 $0.420 risen by 1,254.84%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2022 7:49PM $0.033 $0.420 risen by 1,172.73%
$18 General Meeting Notice of Meeting 14 Jan 2022 10:15AM $0.041 $0.420 risen by 924.39%
$18 General Meeting Notice of Access/Proxy Form 14 Jan 2022 10:15AM $0.041 $0.420 risen by 924.39%
$18 Response to ASX Query 12 Jan 2022 5:15PM $0.043 $0.420 risen by 876.74%
$18 ArtemiC receives Indian importation and sales approval 7 Jan 2022 9:54AM $0.041 $0.420 risen by 924.39%
$18 ArtemiC Long COVID Syndrome Clinical Study Commenced 21 Dec 2021 9:05AM $0.037 $0.420 risen by 1,035.14%
$18 Notification regarding unquoted securities - MXC 16 Dec 2021 3:06PM $0.038 $0.420 risen by 1,005.26%
$18 s708A(5)(e) Cleansing Notice 8 Dec 2021 1:30PM $0.040 $0.420 risen by 950%
$18 Application for quotation of securities - MXC 8 Dec 2021 1:23PM $0.040 $0.420 risen by 950%
$18 Application for quotation of securities - MXC 8 Dec 2021 1:23PM $0.040 $0.420 risen by 950%
$18 s708A(5)(e) Cleansing Notice 1 Dec 2021 3:09PM $0.041 $0.420 risen by 924.39%
$18 Proposed issue of securities - MXC 1 Dec 2021 12:07PM $0.041 $0.420 risen by 924.39%
$18 UK Capital Raising Completed 1 Dec 2021 12:07PM $0.041 $0.420 risen by 924.39%

226 - 250 of 818 results

Page 10 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.